## **Core Concept**
The question tests knowledge of immunology, specifically histocompatibility antigens, also known as Human Leukocyte Antigens (HLA). HLA typing is crucial in transplant medicine and immunology research. Class I histocompatibility antigens are expressed on the surface of almost all nucleated cells and platelets.

## **Why the Correct Answer is Right**
The correct answer, , involves the use of **complement-dependent cytotoxicity (CDC) assay** or more specifically for HLA typing, **microlymphocytotoxicity assay**. This test is a standard method for HLA class I and class II typing. It relies on the principle that when antibodies bind to HLA antigens on the surface of lymphocytes, complement activation can lead to cell lysis. By using specific antisera that recognize particular HLA alleles, this method can identify which HLA class I antigens are present on the cells.

## **Why Each Wrong Option is Incorrect**
- **Option A:** This could potentially refer to other methods, but without specifics, it's hard to directly refute. However, given that is the correct answer, we can infer A is not the best choice.
- **Option B:** This might refer to another technique, but again, specifics are needed for a direct refutation. The focus here is on as the method related to histocompatibility antigen typing.
- **Option D:** Similarly, without specifics, it's challenging to directly address why D is incorrect, other than acknowledging as the correct method.

## **Clinical Pearl / High-Yield Fact**
A key point to remember is that **HLA typing** is critical in **organ transplantation** to minimize the risk of **rejection**. The **complement-dependent cytotoxicity assay** is a traditional and widely used method for this purpose. Understanding the principles behind HLA typing and its applications in clinical medicine is essential for postgraduate medical students.

## **Correct Answer:** .